Mark Kong CFA
Stock Analyst at DBS
(1.74)
# 3,409
Out of 5,073 analysts
30
Total ratings
52.6%
Success rate
0.3%
Average return
Main Sectors:
Stocks Rated by Mark Kong CFA
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HKG: 6160 BeOne Medicines AG | Reiterated: Buy | $290.00 | $233.00 | +24.46% | 5 | Sep 28, 2026 | |
| HKG: 1681 Consun Pharmaceutical Group Limited | Reiterated: Buy | $26.00 | $15.70 | +65.61% | 6 | Sep 17, 2026 | |
| HKG: 1801 Innovent Biologics, Inc. | Reiterated: Buy | $144.00 | $88.95 | +61.89% | 3 | Sep 15, 2026 | |
| HKG: 1093 CSPC Pharmaceutical Group Limited | Initiated Coverage: Buy | $13.70 | $8.73 | +57.02% | 1 | Sep 10, 2026 | |
| HKG: 1177 Sino Biopharmaceutical Limited | Initiated Coverage: Buy | $6.50 | $5.34 | +21.72% | 1 | May 20, 2026 | |
| HKG: 2105 Laekna, Inc. | Reiterated: Buy | $24.16 | $6.15 | +292.85% | 6 | Mar 20, 2026 | |
| HKG: 1099 Sinopharm Group Co. Ltd. | Upgraded: Buy | $25.00 | $15.74 | n/a | 1 | Dec 12, 2024 | |
| HKG: 1515 China Resources Medical Holdings Company Limited | Reiterated: Buy | $7.50 | $2.37 | n/a | 2 | Oct 24, 2024 | |
| SNY Sanofi | Reiterated: Buy | n/a | $41.40 | n/a | 1 | Oct 11, 2024 | |
| VRTX Vertex Pharmaceuticals | Reiterated: Hold | n/a | $514.65 | n/a | 2 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $289.08 | n/a | 1 | Sep 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $242.08 | n/a | 1 | Sep 13, 2024 |
BeOne Medicines AG
Sep 28, 2026
Reiterated: Buy
Price Target: $290.00
Current: $233.00
Upside: +24.46%
Consun Pharmaceutical Group Limited
Sep 17, 2026
Reiterated: Buy
Price Target: $26.00
Current: $15.70
Upside: +65.61%
Innovent Biologics, Inc.
Sep 15, 2026
Reiterated: Buy
Price Target: $144.00
Current: $88.95
Upside: +61.89%
CSPC Pharmaceutical Group Limited
Sep 10, 2026
Initiated Coverage: Buy
Price Target: $13.70
Current: $8.73
Upside: +57.02%
Sino Biopharmaceutical Limited
May 20, 2026
Initiated Coverage: Buy
Price Target: $6.50
Current: $5.34
Upside: +21.72%
Laekna, Inc.
Mar 20, 2026
Reiterated: Buy
Price Target: $24.16
Current: $6.15
Upside: +292.85%
Sinopharm Group Co. Ltd.
Dec 12, 2024
Upgraded: Buy
Price Target: $25.00
Current: $15.74
Upside: n/a
China Resources Medical Holdings Company Limited
Oct 24, 2024
Reiterated: Buy
Price Target: $7.50
Current: $2.37
Upside: n/a
Sanofi
Oct 11, 2024
Reiterated: Buy
Price Target: n/a
Current: $41.40
Upside: n/a
Vertex Pharmaceuticals
Oct 8, 2024
Reiterated: Hold
Price Target: n/a
Current: $514.65
Upside: n/a
Sep 13, 2024
Reiterated: Hold
Price Target: n/a
Current: $289.08
Upside: n/a
Sep 13, 2024
Reiterated: Buy
Price Target: n/a
Current: $242.08
Upside: n/a